Krüppel-like factor 6 regulates mitochondrial function in the kidney

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 1347-1361

  Mallipattu, Sandeep K ^a   Horne, Sylvia J ^a   D'Agati, Vivette ^b   Narla, Goutham ^c   Liu, Ruijie ^d   Frohman, Michael A ^a   Dickman, Kathleen ^a   Chen, Edward Y ^d   Ma'ayan, Avi ^d   Bialkowska, Agnieszka B ^a   Ghaleb, Amr M ^a   Nandan, Mandayam O ^a   Jain, Mukesh K ^c   Daehn, Ilse ^d   Chuang, Peter Y ^d   Yang, Vincent W ^a   He, John C ^d,e  

^a STONY BROOK UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; CYTOCHROME C OXIDASE; DOXORUBICIN; KRUPPEL LIKE FACTOR 6; COPEB PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; ONCOPROTEIN; SCO2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BINDING SITE; CELL FUNCTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; FOCAL GLOMERULOSCLEROSIS; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CELL; KIDNEY MITOCHONDRIA; MITOCHONDRIAL INJURY; MITOCHONDRION; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; APOPTOSIS; BINDING SITES; CELLS, CULTURED; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; PODOCYTES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS;

EID: 84924061314     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77084     Document Type: Article

References (46)

1. Meyrier A. Mechanisms of disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol. 2005;1(1):44-54.
2. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71(12):1205-1214.
3. Holthofer H, et al. Altered gene expression and functions of mitochondria in human nephrotic syndrome. FASEB J. 1999;13(3):523-532.
4. Solin ML, Pitkanen S, Taanman JW, Holthofer H. Mitochondrial dysfunction in congenital nephrotic syndrome. Lab Invest. 2000;80(8):1227-1232.
5. Barisoni L, et al. Collapsing glomerulopathy associated with inherited mitochondrial injury. Kidney Int. 2008;74(2):237-243.
6. Papeta N, et al. Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest. 2010;120(11):4055-4064.
7. McConnell BB,Yang VW Mammalian Kruppellike factors in health and diseases Physiol Rev. 2010, 90, 4, 1337-1381.
8. Cohen CD, et al. Comparative promoter analysis allows de novo identification of specialized cell junction-Associated proteins. Proc Natl Acad Sci U S A. 2006;103(15):5682-5687.
9. Mallipattu SK, et al. Kruppel-Like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem. 2012;287(23):19122-19135.
10. Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology. 2011;16(1):30-38.
11. Tew ey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;226(4673):466-468.
12. Adachi K, et al. A de letion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun. 1993;195(2):945-951.
13. Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA. Ti ssue-specific mtDNA lesions and radical-Associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol. 2005;207(4):436-444.
14. Suliman HB, Carraway MS, Ali AS, Reynolds C M, Welty-Wolf KE, Piantadosi CA. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest. 2007;117(12):3730-3741.
15. Matys V, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003;31(1):374-378.
16. Pecina P, Houstkova H, Hansikova H, Zeman J, Houstek J. Genetic defects of cytochrome c oxidase assembly. Physiol Res. 2004; 53(suppl 1):S213-S223.
17. Banci L, et al. A structural characterization of human SCO2. Structure. 2007;15(9):1132-1140.
18. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin ca rdiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000;60(7):1789-1792.
19. Liu TJ, et al. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes. Cardiovasc Res. 2008;80(2):227-235.
20. Yeh YC, et al. A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosi s in rat testes. Br J Pharmacol. 2009;156(1):48-61.
21. Mallipattu SK, et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int. 2013;83(4):626-634.
22. Zhang R, Han M, Zheng B, Li YJ, Shu YN, Wen JK. Kruppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs. Acta Pharmacol Sin. 2010;31(10):1293-1302.
23. Johar K, Priya A, Dhar S, Liu Q, Wong-Riley MT. Neuron-specific specificity protein 4 bigenomically regulates the transcription of all mitochondria-And nucleus-encode d cytochrome c oxidase subunit genes in neurons. J Neurochem. 2013;127(4):496-508.
24. Ross MJ, Martinka S, D'Agati VD, Bruggeman LA. NF-?B regulates Fas-mediated apoptosis in HIV-Associated nephropathy. J Am Soc Nephrol. 2005;16(8):2403-2411.
25. Chuang PY, Yu Q, Fang W, Uribarri J, He JC. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 tran scription factor. Kidney Int. 2007;72(8):965-976.
26. Papadopoulou LC, et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet. 1999;23(3):333-337.
27. Jaksch M, et al. Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet. 2000;9(5):795-801.
28. He JC,et al Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways J Clin Invest. 2004 114 5 643-651.
29. He JC, et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol. 2007;18(1):93-102.
30. Smeets B, et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22(7):1262-1274.
31. Husain M, et al. Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem. 2009;284(24):16648-16658.
32. Snyder A, et al. FAT10: a nov el mediator of Vpr-induced apoptosis in human immunodeficiency virus-Associated nephropathy. J Virol. 2009;83(22):11983-11988.
33. Dickie P, et al. HIV-Associated nephropathy in transgenic mice expressing HIV-1 genes. Virology. 1991;185(1):109-119.
34. Feng X, et al. Reduction of Stat3 activity attenuates HIV-induced kidney injury. J Am Soc Nephrol. 2009;20(10):2138-2146.
35. Leow CC, et al. Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway. J Biol Chem. 2009;284(31):21057-21065.
36. Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc. 2006;1(2):729-748.
37. Takemoto M, et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol. 2002;161(3):799-805.
38. Katsuya K, Yaoita E, Yoshida Y, Yamamoto Y, Yamamoto T. An improved method for primary culture of rat podocytes. Kidney Int. 2006;69(11):2101-2106.
39. Husain M, et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol. 2002;13(7):1806-1815.
40. Guo J, et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J Am Soc Nephrol. 2008;19(5):961-972.
41. Huang H, et al. piRNA-Associated germline nuage formation and spermatogenesis require MitoPLD profusogenic mitochondrial-surface lipid signaling. Dev Cell. 2011;20(3):376-387.
42. Favre C, Zhdanov A, Leahy M, Papkovsky D, O'Connor R. Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells. Oncogene. 2010;29(27):3964-3976.
43. Zhdanov AV, Ward MW, Prehn JH, Papkovsky DB. Dynamics of intracellular oxygen in PC12 cells upon stimulation of neurotransmission. J Biol Chem. 2008;283(9):5650-5661.
44. Mallipattu SK, et al. Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2014;306(9):F1008-F1017.
45. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int. 2010;78(11):1171-1177.
46. Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119(5):1275-1285.